Natural killer cells in tumor immunotherapy

Dongyao Wang; Haiming Wei

doi:10.20892/j.issn.2095-3941.2023.0215

Natural killer cells in tumor immunotherapy

Cancer Biol Med. 2023 Aug 26;20(8):539-544. doi: 10.20892/j.issn.2095-3941.2023.0215.

Authors

Dongyao Wang^{1

2

3

4}, Haiming Wei^{1

2

3}

Affiliations

¹ Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China.
² Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medicine and Medical Center, University of Science and Technology of China, Hefei 230001, China.
³ The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medicine and Medical Center, University of Science and Technology of China, Hefei 230027, China.
⁴ Blood and Cell Therapy Institute, Anhui Provincial Key Laboratory of Blood Research and Applications, University of Science and Technology of China, Hefei 230027, China.

PMID: 37646229
PMCID: PMC10476468
DOI: 10.20892/j.issn.2095-3941.2023.0215

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunotherapy*
Killer Cells, Natural
Neoplasms* / therapy

Grants and funding

This work was supported by the National Natural Science Foundation of China (Grant No. 82100230), the Fundamental Research Funds for the Central Universities (Grant No. YD9110002019), and the Outstanding Youth Project of Anhui Scientific Research Compilation Plan (Grant No. 2022AH030128).